Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern Sudan
Open Access
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (5) , 612-619
- https://doi.org/10.1086/381203
Abstract
We analyzed data obtained from 3365 patients with kala-azar (KA) or post-KA dermal leishmaniasis (PKDL) treated by Médecins Sans Frontières–Holland iKeywords
This publication has 10 references indexed in Scilit:
- Visceral leishmaniasis and HIV in Tigray, EthiopiaTropical Medicine & International Health, 2003
- Post-kala-azar dermal leishmaniasisThe Lancet Infectious Diseases, 2003
- 1. Cutaneous leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian EpidemicClinical Infectious Diseases, 2000
- Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan.Health Policy and Planning, 1999
- The Epidemic of Visceral Leishmaniasis in Western Upper Nile, Southern Sudan: Course and Impact from 1984 to 1994International Journal of Epidemiology, 1996
- Epidemic Visceral Leishmaniasis in Southern Sudan: Treatment of Severely Debilitated Patients under Wartime Conditions and with Limited ResourcesAnnals of Internal Medicine, 1996
- Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate AloneThe Journal of Infectious Diseases, 1993
- Incrimination of Phlebotomus (Larroussius) orientalis as a vector of visceral leishmaniasis in western Upper Nile Province, southern SudanTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditionsPathogens and Global Health, 1992